7 results match your criteria: "Hospital Irma de Lourdes Tzanetatos[Affiliation]"
Open Forum Infect Dis
November 2024
Sanatorio Las Lomas, Buenos Aires, Argentina.
Antimicrob Resist Infect Control
November 2024
Sanatorio Las Lomas, Av. Diego Carman 555, San Isidro, Provincia de Buenos Aires, B1642 , Argentina.
Background: Infection prevention and control (IPC) programs are essential to prevent and control the spread of multidrug-resistant organisms in healthcare facilities (HCFs). The current implementation of these programs in Latin America remains largely unknown.
Methods: We conducted a mixed-methods evaluation of IPC program implementation in HCFs from Guatemala, Panama, Ecuador, and Argentina, March-July 2022.
Am J Infect Control
February 2025
Sanatorio Las Lomas, Buenos Aires, Argentina. Electronic address:
Antimicrob Resist Infect Control
April 2024
Sanatorio Las Lomas, Buenos Aires, Argentina.
Background: The burden of antimicrobial resistance (AMR) in Latin America is high. Little is known about healthcare workers' (HCWs) knowledge, attitudes, and perceptions of antimicrobial stewardship (AS), AMR, and antibiotic use (AU) in the region.
Methods: HCWs from 42 hospitals from 5 Latin American countries were invited to take an electronic, voluntary, anonymous survey regarding knowledge, attitudes, and perceptions of AS, AMR, and AU between March-April 2023.
Ther Adv Infect Dis
October 2022
Department of Infectious Diseases, Hospital Irma de Lourdes Tzanetatos, Caja del Seguro Social de Panamá, Tocumen 07107, Panama City, Panama.
Introduction: Studies conducted in 1984 demonstrated the presence of in the Darien and Colon provinces. Since then, there have not been further reports of this parasitic infection in Panama.
Methodology: We conducted a cross-sectional assessment of peripheral blood samples of individuals across Panama over a 4-year period (2013-2016) as part of malaria surveillance activities.
Rev Chilena Infectol
June 2022
Departamento de Epidemiologií, Hospital Irma de Lourdes Tzanetatos, Ciudad de Panamá, República de Panamá.
Enterobacterales co-producing carbapenemases have awakened health alerts in Latin America. Carbapenemase-producing Enterobacterales harboring KPC and NDM-1 are resistant to almost all existing antibiotics. Panama reports KPC since 2010, and NDM since 2011, however, Enterobacterales with double carbapenemase production is new to our hospitals.
View Article and Find Full Text PDFTher Adv Infect Dis
December 2021
Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City, Panamá.
Background: The world is currently unprepared to deal with the drastic increase in global migration. There is an urgent need to develop programs to protect the well-being and health of migrant peoples. Increased population movement is already evident throughout the Americas as exemplified by the rising number of migrant peoples who pass through the Darien neotropical moist broadleaf forest along the border region between Panama and Colombia.
View Article and Find Full Text PDF